Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

New treatments for lupus show promise, but more research is needed, especially for children.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

An arthritis drug helped a person with severe hair loss regrow their hair.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

A woman's hair turned white after taking a cancer drug called dasatinib.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Minoxidil affects collagen-related genes, potentially helping treat fibrosis.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Tiny particles carrying roxithromycin can effectively target and deliver the drug to hair follicles without irritation.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Vitexin Compound 1 may help reduce skin aging caused by UVA light.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.